|
|
|
42
|
5281BU
|
CIPROFLOXACIN 0.3% EYE DR (CIP)
|
CIPROFLOXACIN
|
CIPROFLOXACIN
|
10ML
|
BQ
|
1.25
|
1.25
|
BOTT
|
0
|
BOX
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
520404
|
EENT ANTIBACTERIALS
|
2026-04-01
|
|
|
OPHTHALMIC
|
0
|
EENT ANTIBACTERIALS
|
|
|
|
|
40
|
5281BV
|
APROCIN 0.3% EYE DR (ARP/AHI) CIPROFLOXACIN
|
CIPROFLOXACIN
|
APROCIN
|
10ML
|
BH
|
8.15
|
8.15
|
EYE DROP
|
0
|
BOTT
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
520404
|
EENT ANTIBACTERIALS
|
2022-04-01
|
2022-09-30
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
2022-03-29
|
|
|
|
41
|
5281BV
|
APROCIN 0.3% EYE DR (ARP) CIPROFLOXACIN (BH)
|
CIPROFLOXACIN
|
APROCIN
|
10ML
|
BH
|
8.15
|
8.15
|
BOTT
|
0
|
BOTT
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
520404
|
EENT ANTIBACTERIALS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
EENT ANTIBACTERIALS
|
|
|
|
|
41
|
5282E
|
APROCIN 0.3% OINT (ARP) CIPROFLOXAC (BH)
|
CIPROFLOXACIN
|
APROCIN
|
3G
|
BH
|
2.64
|
2.6368
|
TUBE
|
0
|
BOX
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
520404
|
EENT ANTIBACTERIALS
|
2024-04-01
|
2026-03-31
|
|
TOPICAL
|
0
|
EENT ANTIBACTERIALS
|
|
|
|
|
42
|
5282E
|
APROCIN 0.3% OINT (ARP) CIPROFLOXAC
|
CIPROFLOXACIN
|
APROCIN
|
3G
|
BH
|
2.72
|
2.72
|
TUBE
|
0
|
BOX
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
520404
|
EENT ANTIBACTERIALS
|
2026-04-01
|
|
|
TOPICAL
|
0
|
EENT ANTIBACTERIALS
|
|
|
|
|
40
|
6451L
|
QUIDEX EYE DROP (LPO/COL) CIPRO/DEXAM
|
CIPROFLOXACIN|DEXAMETHASONE
|
QUIDEX
|
5ML
|
B
|
8.15
|
8.15
|
EYE DROP
|
0
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
COLLINS LTD
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
6451L
|
QUIDEX 0.3%|0.1% EYE DR (LPO) CIPROFLOXACIN|DEXAMETHASONE (BH)
|
CIPROFLOXACIN|DEXAMETHASONE
|
QUIDEX
|
5ML
|
BH
|
8.97
|
8.9705
|
BOTT
|
1
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
COLLINS LTD
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
6451L
|
QUIDEX 0.3%|0.1% EYE DR (LPO) CIPROFLOXACIN|DEXAMETHASONE
|
CIPROFLOXACIN|DEXAMETHASONE
|
QUIDEX
|
5ML
|
B
|
16.31
|
16.31
|
BOTT
|
1
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
AVENTA BARBADOS
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
|
|
OPHTHALMIC
|
6
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
6451Y
|
CIPRODEX 0.3% | 0.1% EAR DR (NVS/COL) CIPROFLOX
|
CIPROFLOXACIN|DEXAMETHASONE
|
CIPRODEX
|
7.5ML
|
C
|
29.68
|
29.68
|
EAR DROP
|
0
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
6711BB
|
ZINDOLIN 500MG TAB (REM) CIPROFLOXACIN (C)
|
CIPROFLOXACIN
|
ZINDOLIN
|
10X10
|
C
|
16.96
|
0.1696
|
TAB
|
14
|
BOX
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
081218
|
QUINOLONES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
QUINOLONES
|
|
|
|
|
42
|
6711BB
|
ZINDOLIN 500MG TAB (REM) CIPROFLOXACIN
|
CIPROFLOXACIN
|
ZINDOLIN
|
10X10
|
C
|
24.82
|
0.25
|
TAB
|
14
|
BLIS
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
081218
|
QUINOLONES
|
2026-04-01
|
|
|
ORAL
|
0
|
QUINOLONES
|
|
|
|
|
40
|
6711CY
|
CIPROFLOXACIN 500MG TAB (HEA/RXP)
|
CIPROFLOXACIN
|
CIPROFLOXACIN
|
10X10
|
A
|
14.81
|
0.15
|
TABLET
|
14
|
TAB
|
HEA
|
HEALTH 2000 INC
|
RXP
|
RX PRO INC
|
|
081218
|
QUINOLONES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
6711DA
|
CIPROXINA 500MG TAB (BSP) CIPROFLOXACIN (C)
|
CIPROFLOXACIN
|
CIPROXINA
|
30'S
|
C
|
81.55
|
2.7183
|
TAB
|
14
|
BOX
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081218
|
QUINOLONES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
QUINOLONES
|
|
|
|
|
42
|
6711DA
|
CIPROXINA 500MG TAB (BSP) CIPROFLOXACIN
|
CIPROFLOXACIN
|
CIPROXINA
|
30'S
|
C
|
57.08
|
1.90
|
TAB
|
14
|
BLIS
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081218
|
QUINOLONES
|
2026-04-01
|
|
|
ORAL
|
0
|
QUINOLONES
|
|
|
|
|
40
|
6711HB
|
CIPROFLOXACIN 500MG TAB (HEA/ATB)
|
CIPROFLOXACIN
|
CIPROFLOXACIN
|
10X10
|
A
|
14.81
|
0.1481
|
TABLET IMMED
|
14
|
|
HEA
|
HEALTH 2000 INC
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
81218
|
QUINOLONES
|
2022-07-12
|
2024-03-31
|
la
|
oral
|
0
|
QUINOLONES
|
2022-11-25
|
|
|
|
41
|
6711HB
|
CIPROFLOXACIN 500MG TAB (HEA)
|
CIPROFLOXACIN
|
CIPROFLOXACIN
|
10X10
|
A
|
14.87
|
0.1487
|
TAB
|
14
|
BOX
|
HEA
|
HEALTH 2000 INC
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
081218
|
QUINOLONES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
QUINOLONES
|
|
|
|
|
42
|
6711LQ
|
CIPROFLOXACIN 500MG TAB (MCP)
|
CIPROFLOXACIN
|
CIPROFLOXACIN
|
10X10
|
A
|
8.10
|
0.08
|
TAB
|
14
|
BLIS
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081218
|
QUINOLONES
|
2026-04-01
|
|
|
ORAL
|
0
|
QUINOLONES
|
|
|
|
|
41
|
6711LW
|
VANCIP 500MG TAB (TPP) CIPROFLOXACIN
|
CIPROFLOXACIN
|
VANCIP
|
10X10
|
A
|
13.84
|
0.1384
|
TAB
|
14
|
BOX
|
TPP
|
THERDOSE PHARMA PRIVATE LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081218
|
QUINOLONES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
QUINOLONES
|
|
|
|
|
42
|
6711MS
|
CIPROFLOXACIN 500MG TAB (HEA)
|
CIPROFLOXACIN
|
CIPROFLOXACIN
|
10X10
|
A
|
15.74
|
0.16
|
TAB
|
14
|
BLIS
|
HEA
|
HEALTH 2000 INC
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081218
|
QUINOLONES
|
2026-04-01
|
|
Price Change
|
ORAL
|
0
|
QUINOLONES
|
2025-10-31
|
|
|
|
42
|
6711NK
|
CIPROFLOXACIN 500MG TAB (HEA)
|
CIPROFLOXACIN
|
CIPROFLOXACIN
|
10X10
|
A
|
15.74
|
0.16
|
TAB
|
14
|
BLIS
|
HEA
|
HEALTH 2000 INC
|
CWS
|
CAPSULE WHOLESALE
|
|
081218
|
QUINOLONES
|
2026-04-01
|
|
Add to Contract as Cat A
|
ORAL
|
0
|
QUINOLONES
|
2026-01-26
|
